Leadership Overview
New England Biolabs has 4 executives leading key functions including strategy, finance, information technology, and international operations.
Driven by innovation, New England Biolabs is dedicated to advancing life science research through the development and supply of high-quality enzyme reagents and supporting solutions for genome editing, synthetic biology, and next-generation sequencing, reinforcing its commitment to scientific progress and accessibility.
Driven by innovation, New England Biolabs is dedicated to advancing life science research through the development and supply of high-quality enzyme reagents and supporting solutions for genome editing, synthetic biology, and next-generation sequencing, reinforcing its commitment to scientific progress and accessibility.
Leadership Roles at New England Biolabs
Salvatore Russello - Chief Executive Officer
Salvatore Russello, the Chief Executive Officer at New England Biolabs, directs the company's overall strategic vision and operational execution. Russello guides the organization's commitment to producing and supplying recombinant and native enzyme reagents essential for life science research. This leadership encompasses fostering innovation in areas such as genome editing, synthetic biology, and next-generation sequencing. Salvatore Russello ensures the company's continued provision of free access to critical research tools like REBASE, InBASE, and Polbase, underscoring NEB's dedication to advancing scientific discovery globally. The Chief Executive Officer's role involves aligning departmental objectives with the company's long-standing mission to support researchers worldwide, driving growth and maintaining NEB's position as a leader in the biotechnology sector.
Richard Ireland - Chief Financial Officer
Richard Ireland, the Chief Financial Officer at New England Biolabs, manages all fiscal operations and financial strategy. Ireland oversees the company's financial health, ensuring robust resource allocation for research, development, and production of enzyme reagents. This involves meticulous budgeting, forecasting, and financial reporting to support NEB's mission in life science research, genome editing, and next-generation sequencing. Richard Ireland's financial oversight extends to managing investments in new technologies and maintaining the company's private ownership structure. The Chief Financial Officer plays a crucial part in sustaining the free access provided to research tools like REBASE and InBASE, balancing operational costs with the company's commitment to scientific accessibility. Ireland's expertise ensures financial stability and supports strategic expansion initiatives.
Hiroshi Toshishige - Neb Inc President & General Manager (Japan)
Hiroshi Toshishige, the Neb Inc President & General Manager (Japan) at New England Biolabs, spearheads the company's strategic initiatives and operational management within the Japanese market. Toshishige drives the expansion and delivery of NEB's recombinant and native enzyme reagents, supporting life science research, genome editing, and next-generation sequencing across Japan. This leadership role involves adapting global strategies to local market needs, ensuring robust supply chain operations, and fostering strong relationships with Japanese researchers and institutions. Hiroshi Toshishige oversees the localized implementation of NEB's commitment to providing essential research tools, including REBASE and InBASE, to the scientific community in Japan. The Neb Inc President & General Manager (Japan) ensures compliance with regional regulations and contributes significantly to NEB's international growth objectives, reinforcing the company's global impact.
Lennox Brown - Chief Information Officer & Director, Information Technology
Lennox Brown, the Chief Information Officer & Director, Information Technology at New England Biolabs, architects and directs the company's technological infrastructure and digital strategy. Brown is responsible for implementing and managing IT systems that support the production and supply of enzyme reagents for life science research, genome editing, and next-generation sequencing. This includes ensuring the integrity and accessibility of NEB's research tools such as REBASE and Polbase. Lennox Brown oversees cybersecurity measures, data management, and the integration of advanced technologies to enhance operational efficiency and support scientific innovation. The Chief Information Officer & Director, Information Technology ensures seamless digital operations, facilitating collaboration among research teams and supporting the company's global market presence. Brown's leadership drives technological advancements critical to NEB's mission.
Explore Leadership Teams in Manufacturing
Bristol-Myers Squibb operates as a global biopharmaceutical organization dedicated to discovering, developing, and manufacturing prescription medications that address serious patient needs across multiple therapeutic domains. The company's scientific expertise spans oncology, cardiovascular disease, immunoscience, and virology, with particular depth in treating complex conditions including HIV and cancer. Through sustained investment in research and development, the organization has built a comprehensive medication portfolio that combines innovative cancer immunotherapies, anticoagulant therapies, and treatments for chronic viral infections. The company's operational footprint extends across major markets worldwide, enabling efficient distribution and patient access to its therapeutic solutions. Bristol-Myers Squibb pursues a collaborative approach to medical innovation, actively engaging in research partnerships and strategic alliances that accelerate the development of new treatment options. This commitment to external collaboration complements the organization's internal capabilities, creating a dynamic environment where scientific breakthroughs can translate into meaningful therapeutic advances. Bristol-Myers Squibb's medication portfolio reflects decades of pharmaceutical expertise and a strategic focus on disease areas where unmet medical needs remain significant.
Company Leadership MR
BG
BK
JS
Zoetis discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, medicated feed additives that offer medicines to livestock; and other pharmaceutical products, which comprise allergy and dermatology, pain and sedation, antiemetic, reproductive, and oncology products. It markets to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company is headquartered in Parsippany, New Jersey.
Company Leadership KV
KK
RV
Intas was founded in 1976. This company provides the manufacturing and research of pharmaceuticals. Their headquarters are located in Ahmedabad, Gujarat, India.
Company Leadership NC
AV
SR
Janssen PMP (https://www.janssenpmp.com/) is a division of Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Janssen PMP is a long-established world leader in the development and formulation of new and highly effective active substances and end-use products for the protection of materials and food, especially fruits and vegetables. With more than 50 years' experience in Post-Harvest treatments and Plant Protection, Janssen PMP has developed strong technical and commercial expertise. Through protection of our surroundings, we aim to protect the health and well-being of the people in the environment in which our products are being used.
Company Leadership JM
PM
TF
LY
Frequently Asked Questions Regarding New England Biolabs Top Executives and Leadership Team
